These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10402158)

  • 21. Controlling the abuse of illicit methadone in Washington, DC.
    Greene MH; Brown BS; DuPont RL
    Arch Gen Psychiatry; 1975 Feb; 32(2):221-6. PubMed ID: 1115569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone maintenance, pregnancy, and progeny.
    Blinick G; Jerez E; Wallach RC
    JAMA; 1973 Jul; 225(5):477-9. PubMed ID: 4740334
    [No Abstract]   [Full Text] [Related]  

  • 24. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.
    Brown LS; Sawyer RC; Li R; Cobb MN; Colborn DC; Narang PK
    Drug Alcohol Depend; 1996 Dec; 43(1-2):71-7. PubMed ID: 8957145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing the risk of AIDS through methadone maintenance treatment.
    Ball JC; Lange WR; Myers CP; Friedman SR
    J Health Soc Behav; 1988 Sep; 29(3):214-26. PubMed ID: 3241064
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use.
    Iguchi MY; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1988 Oct; 22(1-2):1-7. PubMed ID: 2906863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone disks. Injectable-noninjectable tablets.
    Jaffe JH; Fritz K; Kaistha KK
    Arch Gen Psychiatry; 1971 Dec; 25(6):525-6. PubMed ID: 5141372
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.
    Berk SI; Litwin AH; Arnsten JH; Du E; Soloway I; Gourevitch MN
    Clin Ther; 2007 Jan; 29(1):131-8. PubMed ID: 17379053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sexual dysfunction and psychological distress in methadone maintenance.
    Spring WD; Willenbring ML; Maddux TL
    Int J Addict; 1992 Nov; 27(11):1325-34. PubMed ID: 1446965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of plasma levels to optimize methadone maintenance treatment.
    Loimer N; Schmid R
    Drug Alcohol Depend; 1992 Aug; 30(3):241-6. PubMed ID: 1396105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methadone-induced pulmonary edema.
    Kjeldgaard JM; Hahn GW; Heckenlively JR; Genton E
    JAMA; 1971 Nov; 218(6):882-3. PubMed ID: 5170934
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program.
    Pani PP; Trogu E; Contu P; Agus A; Gessa GL
    Drug Alcohol Depend; 1997 Nov; 48(2):119-26. PubMed ID: 9363411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of oral preparations of heroin and methadone to stabilise opiate misusers as inpatients.
    Ghodse AH; Creighton FJ; Bhat AV
    BMJ; 1990 Mar; 300(6726):719-20. PubMed ID: 2322723
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.